Sign in to NCBI
Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Cefpirome Treatment Results in Limited Selection of Stable Derepressed Enterobacter cloacae Mutants in the Intestinal Flora of Rats Treated for an Experimental Klebsiella pneumoniae Pulmonary Infection.

Gautam V, Mouton JW, Ten Kate MT, Bakker-Woudenberg IAJM, van Burgh S, Strepis N, Klaassen CHW, Goessens W.

Microb Drug Resist. 2019 Oct 29. doi: 10.1089/mdr.2018.0473. [Epub ahead of print]

PMID:
31657651

Similar articles

2.

Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.

van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF.

Int J Antimicrob Agents. 2019 Aug;54(2):159-166. doi: 10.1016/j.ijantimicag.2019.05.019. Epub 2019 Jun 5.

PMID:
31173867

Similar articles

3.

Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.

Refos JM, Vonk AG, Ten Kate MT, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00960-17. doi: 10.1128/AAC.00960-17. Print 2018 Jan.

PMID:
29084744
Free PMC Article

Similar articles

4.

Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.

Refos JM, Vonk AG, Ten Kate MT, Eadie K, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

PLoS One. 2017 Jul 24;12(7):e0180961. doi: 10.1371/journal.pone.0180961. eCollection 2017.

PMID:
28742113
Free PMC Article

Similar articles

5.

Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.

Monteferrante CG, Sultan S, Ten Kate MT, Dekker LJ, Sparbier K, Peer M, Kostzrewa M, Luider TM, Goessens WH, Burgers PC.

J Antimicrob Chemother. 2016 Oct;71(10):2856-67. doi: 10.1093/jac/dkw208. Epub 2016 Jun 10.

PMID:
27287232

Similar articles

6.

Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.

Bax HI, Bakker-Woudenberg IA, Ten Kate MT, Verbon A, de Steenwinkel JE.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2577-9. doi: 10.1128/AAC.02864-15. Print 2016 Apr.

PMID:
26883697
Free PMC Article

Similar articles

7.

Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.

Bax HI, de Steenwinkel JE, Ten Kate MT, van der Meijden A, Verbon A, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2015 Oct;70(10):2828-37. doi: 10.1093/jac/dkv194. Epub 2015 Jul 16.

PMID:
26183185

Similar articles

8.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Dec;94(6):701-7.

PMID:
25621361

Similar articles

9.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, Ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Oct 13. pii: S1472-9792(14)20507-5. doi: 10.1016/j.tube.2014.09.002. [Epub ahead of print]

PMID:
25423883

Similar articles

10.

Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised rats.

Verwer PE, ten Kate MT, Falcone FH, Morroll S, Verbrugh HA, Bakker-Woudenberg IA, van de Sande WW.

PLoS One. 2013 Oct 14;8(10):e75848. doi: 10.1371/journal.pone.0075848. eCollection 2013.

PMID:
24155872
Free PMC Article

Similar articles

11.

Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.

de Steenwinkel JE, Aarnoutse RE, de Knegt GJ, ten Kate MT, Teulen M, Verbrugh HA, Boeree MJ, van Soolingen D, Bakker-Woudenberg IA.

Am J Respir Crit Care Med. 2013 May 15;187(10):1127-34. doi: 10.1164/rccm.201207-1210OC.

PMID:
23525933

Similar articles

12.

Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in mice.

van den Berg S, Laman JD, Boon L, ten Kate MT, de Knegt GJ, Verdijk RM, Verbrugh HA, Nouwen JL, Bakker-Woudenberg IA.

PLoS One. 2013;8(3):e59107. doi: 10.1371/journal.pone.0059107. Epub 2013 Mar 8.

PMID:
23520553
Free PMC Article

Similar articles

13.

Relapse of tuberculosis versus primary tuberculosis; course, pathogenesis and therapy in mice.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, Verbrugh HA, Hernandez-Pando R, Leenen PJ, Bakker-Woudenberg IA.

Tuberculosis (Edinb). 2013 Mar;93(2):213-21. doi: 10.1016/j.tube.2012.11.006. Epub 2012 Dec 23.

PMID:
23266260

Similar articles

14.

Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis.

de Knegt GJ, Bruning O, ten Kate MT, de Jong M, van Belkum A, Endtz HP, Breit TM, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2013 Jan;93(1):96-101. doi: 10.1016/j.tube.2012.10.013. Epub 2012 Nov 22.

PMID:
23182912

Similar articles

15.

The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats.

Goessens WH, Mouton JW, Ten Kate MT, Sörgel F, Kinzig M, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2013 Jan;57(1):643-6. doi: 10.1128/AAC.01154-12. Epub 2012 Nov 5.

PMID:
23129049
Free PMC Article

Similar articles

16.

Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, Aarnoutse RE, Boeree MJ, den Bakker MA, van Soolingen D, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2012 Sep;56(9):4937-44. doi: 10.1128/AAC.00124-12. Epub 2012 Jul 16.

PMID:
22802244
Free PMC Article

Similar articles

17.

Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Kremer K, Aarnoutse RE, Boeree MJ, Verbrugh HA, van Soolingen D, Bakker-Woudenberg IA.

Emerg Infect Dis. 2012 Apr;18(4):660-3. doi: 10.3201/eid1804.110912.

PMID:
22469099
Free PMC Article

Similar articles

18.

Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, van Belkum A, Hernandez-Pando R, Bakker-Woudenberg IA.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1478-84, i. doi: 10.5588/ijtld.11.0012.

PMID:
22008760

Similar articles

19.

Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, Verbrugh HA, Ottenhoff TH, Bakker-Woudenberg IA.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1195-201. doi: 10.1007/s10096-011-1428-2. Epub 2011 Oct 9.

PMID:
21983896
Free PMC Article

Similar articles

20.

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K, van Soolingen D, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2010 Dec;65(12):2582-9. doi: 10.1093/jac/dkq374. Epub 2010 Oct 14.

PMID:
20947621

Similar articles

21.

Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice.

De Steenwinkel JE, De Knegt GJ, Ten Kate MT, Van Belkum A, Verbrugh HA, Hernandez-Pando R, Van Soolingen D, Bakker-Woudenberg IA.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):723-34.

PMID:
19822089

Similar articles

22.

Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.

van de Sande WW, Mathot RA, ten Kate MT, van Vianen W, Tavakol M, Rijnders BJ, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2009 May;53(5):2005-13. doi: 10.1128/AAC.01556-08. Epub 2009 Feb 23.

PMID:
19237647
Free PMC Article

Similar articles

23.

Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.

van de Sande WW, van Vianen W, ten Kate MT, Vissers J, Laurijsens J, Tavakol M, Rijnders BJ, Mathot RA, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1345-50. doi: 10.1128/AAC.00536-07. Epub 2008 Jan 14.

PMID:
18195059
Free PMC Article

Similar articles

24.

Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.

de Steenwinkel JE, van Vianen W, Ten Kate MT, Verbrugh HA, van Agtmael MA, Schiffelers RM, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2007 Nov;60(5):1064-73. Epub 2007 Sep 10.

PMID:
17846106

Similar articles

25.

Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.

Goessens WH, Mouton JW, ten Kate MT, Bijl AJ, Ott A, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2007 Mar;59(3):507-16. Epub 2007 Feb 8.

PMID:
17289765

Similar articles

26.

Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.

Bakker-Woudenberg IA, ten Kate MT, Goessens WH, Mouton JW.

Antimicrob Agents Chemother. 2006 Sep;50(9):2919-25.

PMID:
16940082
Free PMC Article

Similar articles

27.

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.

van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2006 Apr;57(4):732-40. Epub 2006 Feb 7.

PMID:
16464895

Similar articles

28.

A murine model of Madurella mycetomatis eumycetoma.

Ahmed AO, van Vianen W, ten Kate MT, van de Sande WW, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA.

FEMS Immunol Med Microbiol. 2003 Jun 10;37(1):29-36.

PMID:
12770757
Free Article

Similar articles

29.

Liposome-enabled synergistic interaction of antimicrobial agents.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Liposome Res. 2002 Feb-May;12(1-2):121-7.

PMID:
12604045

Similar articles

30.

Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.

Bakker-Woudenberg IA, ten Kate MT, Guo L, Working P, Mouton JW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2575-81.

PMID:
12121935
Free PMC Article

Similar articles

31.

In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Pharmacol Exp Ther. 2001 Jul;298(1):369-75.

PMID:
11408564

Similar articles

32.

Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.

Bakker-Woudenberg IA, ten Kate MT, Guo L, Working P, Mouton JW.

Antimicrob Agents Chemother. 2001 May;45(5):1487-92.

PMID:
11302815
Free PMC Article

Similar articles

33.

Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.

Schiffelers RM, Storm G, ten Kate MT, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2001 Feb;45(2):464-70.

PMID:
11158742
Free PMC Article

Similar articles

34.

Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

van Etten EW, ten Kate MT, Snijders SV, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1998 Jul;42(7):1677-81.

PMID:
9661003
Free PMC Article

Similar articles

35.

Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.

Storm G, ten Kate MT, Working PK, Bakker-Woudenberg IA.

Clin Cancer Res. 1998 Jan;4(1):111-5.

PMID:
9516959
Free Article

Similar articles

36.

Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.

Leenders AC, de Marie S, ten Kate MT, Bakker-Woudenberg IA, Verbrugh HA.

J Antimicrob Chemother. 1996 Aug;38(2):215-25.

PMID:
8877535

Similar articles

37.

Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.

van Etten EW, ten Kate MT, Stearne LE, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1995 Sep;39(9):1954-8.

PMID:
8540697
Free PMC Article

Similar articles

38.

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages.

Daemen T, Hofstede G, Ten Kate MT, Bakker-Woudenberg IA, Scherphof GL.

Int J Cancer. 1995 May 29;61(5):716-21.

PMID:
7768646

Similar articles

39.

Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.

Bakker-Woudenberg IA, ten Kate MT, Stearne-Cullen LE, Woodle MC.

J Infect Dis. 1995 Apr;171(4):938-47.

PMID:
7706822

Similar articles

40.

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

van Etten EW, Otte-Lambillion M, van Vianen W, ten Kate MT, Bakker-Woudenberg AJ.

J Antimicrob Chemother. 1995 Apr;35(4):509-19.

PMID:
7628985

Similar articles

41.

Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Mouton JW, Woodle MC, Storm G.

J Infect Dis. 1993 Jul;168(1):164-71.

PMID:
8515105

Similar articles

42.

Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Melissen PM, van Vianen W, van Etten EW.

Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S61-7. Review.

PMID:
8477767

Similar articles

43.

Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Storm G.

Biochim Biophys Acta. 1992 Apr 14;1138(4):318-26.

PMID:
1532911

Similar articles

Supplemental Content

Filters: Manage Filters

Loading ...
You are here: NCBI > Literature > PubMed
Support Center